Drug intelligence / Profile preview

Compound Pancreatin Powder

Development stage
Unknown
Lead developer
Ginwa Enterprise Group
Modality
Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
Administration
Oral
01

Overview

Compound Pancreatin Powder is an approved biologic enzyme replacement therapy developed by Jinhua Enterprise (Ginwa) for the treatment of digestive disorders in children, particularly those associated with exocrine pancreatic insufficiency. Administered orally as a powder, the medication provides exogenous pancreatic enzymes—specifically lipase, amylase, and proteases—to assist in the hydrolysis and digestion of fats, carbohydrates, and proteins. This therapy is indicated for patients whose pancreas does not produce sufficient enzymes naturally, thereby facilitating proper nutrient breakdown and absorption in the gastrointestinal tract. It is commonly used to alleviate symptoms of indigestion and malabsorption in pediatric populations.

Brand names
Ginwa
Other names
复方胰酶散Fufang Yimei SanCompound Pancreatic Enzyme Powder
02

Targets

GehA (Triacylglycerol lipase GehA)AMY (Pancreatic alpha-amylase)

Beyond the preview

Go deeper on Compound Pancreatin Powder.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Compound Pancreatin Powder.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call